To explore CCSVI scientifically and provide professional medical care the CCSVI-Center in Frankfurt has assembled a team of Neurologists, diagnostic and interventional Radiologists and Cardiologists for the diagnostic work-up and treatment of patients with CCSVI.
Over the past 12 months we have successfully treated well over 100 patients, without complications.
We have also established international collaborations with research institutions also interested in CCSVI, most notably Prof. Zamboni himself and Profs. Kim and Kabutei from Boston University School of Medicine in the US and are in correspondence with other researchers such as Prof. Haacke.
A preliminary publication of our experience with CCSVI appeared at the RSNA (Radiological Society of North America) meeting in Chicago 2010. We are currently evaluating our data of more than 100 patients for publication and are in the process of setting up a randomized trial of endovascular treatment of CCSVI.
Scientific Evidence versus Ethical Obligation:
CCSVI is an unproven theory and much criticised by Neurologist world-wide. “It is very dangerous and all placebo” the Neurologists say.
We do not agree: As for safety, we have not seen and dangerous complications. But: any kind of medical treatment will cause side effects to some extent, even pharmacotherapy of MS. And for placebo: Well, we do not know for sure until the results from well designed randomised trials are available. But placebo effects usually do not occur in almost all treated patients. And they do not last for as long as a whole year.
In synopsis of the overall safety record of CCSVI treatment and our own experience with patients, particularly in view of the impressive improvements treated patients have experienced, we consider it unethical to withhold this treatment from those patients who are aware of and willing to accept its experimental nature.
60% of patients experienced strong symptom relief, 33% moderate, 7% none...more info on site: